Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H32N2O5 |
Molecular Weight | 416.5106 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CCC[C@@]1([H])N([C@H](C2)C(O)=O)C(=O)[C@@H](C)N[C@H](CCC3=CC=CC=C3)C(=O)OCC
InChI
InChIKey=HDACQVRGBOVJII-YHUYVZNPSA-N
InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9805349
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9805349
Ramipril, (-)- is less active R-enantiomer than S-enantiomer. S-ramipril is angiotensin-converting enzyme (ACE) inhibitor, which is used for the treatment of hypertension.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5COV0OAU1T
Created by
admin on Sat Dec 16 08:29:23 GMT 2023 , Edited by admin on Sat Dec 16 08:29:23 GMT 2023
|
PRIMARY | |||
|
57183875
Created by
admin on Sat Dec 16 08:29:23 GMT 2023 , Edited by admin on Sat Dec 16 08:29:23 GMT 2023
|
PRIMARY | |||
|
1246253-05-3
Created by
admin on Sat Dec 16 08:29:23 GMT 2023 , Edited by admin on Sat Dec 16 08:29:23 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD